In our biomarker-defined subpopulation, we observed a 0.27 effect size on the EMACC cognitive scale after only 6 months (2). For directional context, this magnitude compares favorably to the 18-month ...
PBSV READ THE FULL PBSV RESEARCH REPORT Pharma-Bio Serv, Inc. (OTCQB:PBSV) is a player in the life sciences services sector with a focus on regulatory compliance and consulting support for the ...
INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, presents the following letter to investors from David Moss, CEO: ...
Clinical studies designed to support FDA clearance and planned commercial launch into the world’s largest drug screening market Company ...
Mondelēz International reopens its CoLab Tech accelerator as climate risk, packaging constraints and shifting consumer demand ...
Clinical studies designed to support FDA clearance and planned commercial launch into the world's largest drug screening market Company anticipates full data analysis by the end of March 2026; data ...
Namibia’s Haib copper project is advancing strongly, with Koryx Copper completing a positive PEA in September 2025.
1d
As Colorado’s wildfire threat grows, Douglas County turns to biochar as ‘next level’ mitigation tool
Biochar as a material is not novel. It has been produced by humans for more than 2,000 years. But churning out the material ...
Dr. Maik Luu discusses how postbiotics can be used to reprogram CAR T cells to promote anti-tumor function and what further research is needed to bring probiotic-boosted therapies to the clinic.
According to MarketsandMarkets™, the Microfluidics Market is projected to grow from about USD 24.96 billion in 2025 to USD 37.2 billion ...
The influenza observation, together with MindWalk's previously disclosed HYFT-enabled dengue epitope program, shows HYFT as a cross-pathogen platform for identifying conserved functional design rules ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results